L3Harris Technologies Inc SEC Filings

L3Harris Technologies (LHX) Chair and CEO Christopher E. Kubasik reported insider transactions. On 11/13/2025, he exercised 14,171 non‑qualified stock options at $162.30 per share (code M) and sold 14,171 shares at $301.05 (code S) pursuant to a Rule 10b5‑1(c) plan adopted on June 13, 2025.

Following these transactions, he directly owned 144,426 shares and held 30,000 shares indirectly via a grantor retained annuity trust. A separate transaction (code I) disposed of 1,156.37 shares held through the issuer’s retirement plan at $288.37, leaving 0 shares via the plan. The footnote notes plan-based adjustments of 1,151.82 shares excluded and 4.56 shares acquired as of 11/13/2025.

LHX filed a Form 144 notice for a proposed sale of 14,171 common shares, reflecting an aggregate market value of $4,266,179.55. The broker listed is Fidelity Brokerage Services LLC, with sales noted for the NYSE and an approximate sale date of November 13, 2025.

The shares to be sold were acquired on November 13, 2025 via options originally granted on February 20, 2018, with payment in cash. As context, shares outstanding were 187,052,847. The filing also lists a prior sale over the past three months: 83,000 shares sold on September 12, 2025 for $23,231,542.30.

L3Harris Technologies (LHX) filed a Form 4 reporting equity transactions by an officer, the President of Integrated Mission Systems, on 11/01/2025. The filing shows 4,147 shares of common stock issued upon the vesting of restricted stock units (code M) at $0. To cover taxes, 1,632 shares were withheld (code F) at a price of $289.10 per share.

After these transactions, the officer beneficially owned 5,415.18 shares directly. This total includes 103.18 shares acquired through the company’s retirement plan as of 10/03/2025. The RSU grant vested in three tranches on 11/01/2023, 11/01/2024, and 11/01/2025, and no derivative RSUs remain from this grant.

L3Harris Technologies reported third-quarter 2025 results with revenue of $5,659 million (up from $5,292 million) and diluted EPS of $2.46 (up from $2.10). Operating income rose to $621 million from $495 million as all segments contributed, led by Space & Airborne Systems at $1,809 million and Aerojet Rocketdyne at $755 million.

The effective tax rate increased to 18.5% from 6.0%, primarily reflecting the enacted OBBBA tax changes and the CAS divestiture. Year to date, cash from operations was $1,144 million. Capital returns included $998 million of share repurchases and $678 million in dividends. The CAS business sale provided $831 million in net proceeds and resulted in a $17 million pre-tax loss.

Backlog stood at $36.3 billion; the company expects to recognize about 45% over the next 12 months. As of October 3, cash was $339 million, long-term debt totaled $11,117 million, and commercial paper outstanding was $725 million. New credit lines include a $2.5 billion five-year and $500 million 364‑day facility, both undrawn.

L3Harris Technologies, Inc. (LHX) reported that it released its third‑quarter financial results and furnished the earnings release as Exhibit 99.1 on an 8‑K.

The company stated the materials provided under Item 2.02, including Exhibit 99.1, are furnished and not deemed “filed” under Section 18 of the Exchange Act, and will not be incorporated by reference into other filings unless specifically referenced.

David S. Regnery, a director of L3Harris Technologies, Inc. (LHX), received a credit of 124.8 phantom stock units under the companys 2019 Non-Employee Director Compensation Plan as reported for a 10/01/2025 transaction. The phantom units reflect a prior election to defer part of his non-employee director cash retainer and are payable in shares of the issuers common stock upon his separation from service. Following the credited units (including 6.82 phantom units added via dividend credits since last reported), the reporting persons beneficial holdings total 1,768.36 shares on a direct basis. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Christopher E. Kubasik, Chair and CEO of L3Harris Technologies (LHX), reported option exercise and a contemporaneous sale on 09/12/2025 under a Rule 10b5-1 plan. He exercised 83,000 non-qualified stock options with an exercise price of $162.30 per share that were originally granted 06/29/2019 and expire 02/20/2028, resulting in acquisition of 83,000 shares. The reporting person then sold 83,000 shares at a weighted-average price in the reported range of $278.30 to $281.62 (disclosed average shown as $279.90). Following these transactions, beneficial ownership is reported as 145,577.82 shares directly and indirectly, which includes 30,000 shares held indirectly through a grantor retained annuity trust.

L3Harris Technologies, Inc. (LHX) Rule 144 notice shows a proposed sale of 83,000 common shares through Fidelity Brokerage Services with an aggregate market value of $23,231,539.66, scheduled approximately for 09/12/2025 on the NYSE. The filing states these shares were acquired as an option granted on 02/20/2018 and the intended payment method is cash. The filer also disclosed three prior sales by Christopher E. Kubasik within the past three months: 33,061 shares on 06/12/2025 for $8,214,825.36, 72,000 shares on 07/29/2025 for $19,521,698.40, and 40,138 shares on 08/11/2025 for $10,818,005.80. The notice includes the standard insider representation that no undisclosed material adverse information is known.

Christopher E. Kubasik, Chair and CEO and a director of L3Harris Technologies (LHX), reported transactions dated 08/11/2025 involving company common stock. The filing shows a sale of 40,138 shares with weighted average sale prices reported in a range of $267.99 to $270.63. The report also discloses a non-qualified stock option position with an exercise price of $149.31 covering 40,138 shares (exercisable 06/29/2019, expiring 12/20/2027). The filing notes 30,000 shares held indirectly by a grantor retained annuity trust. All transactions were reported on a Form 4 signed by an attorney-in-fact.